The size of the Breast Imaging market in Europe is anticipated to grow at 8.64% CAGR from 2020 to 2025, and it is valued at USD 0.85 billion in 2020 and is expected to reach USD 1.28 billion by 2025.
Increasing commercialization of healthcare system because of the rise in the number of people undergoing advanced treatments owing to schemes like statutory health insurance, enhancements in breast imaging modalities, greater extent of public funding in Europe’s healthcare system, the higher occurrence rate of breast cancer alongside government backing for cancer prevention are majorly accelerating the breast imaging market in Europe.
Emerging economies of the European countries like Germany, Spain, France, UK, Italy, and remaining countries, are expected to provide opportunities for the growth of the Europe Breast imaging market. Due to increasing healthcare expenditures in the United Kingdom resulting in product and service portfolio expansion, which is likely to fuel the growth of the Breast Imaging market in the region, it will impact the growth of the European breast imaging market during the forecast period.
The evolution of advanced imaging systems like nuclear imaging, ultrasound, MRI, near infra-red optical imaging, bioelectric imaging, and the changes in reimbursement policies, are the factors anticipated to advance the growth opportunities for the Europe Breast imaging market.
Furthermore, the increase in private and government investments for the development of innovative and advanced breast imaging technologies due to the growing demand for breast cancer screenings is boosting the European breast imaging market.
Certain limitations are opposing the growth of the European breast imaging market. They are, the high cost of breast imaging systems and budget restrictions, patients may face psychological health issues due to radiation exposure, expensive installation, and maintenance costs.
Regionally, Europe held the second-largest market share due to the increased expenditure in the development of futuristic technologies coupled with the rising awareness amongst patients.
Some of the Prominent Companies leading the Europe Breast Imaging Market Profiled in the Report are Hologic, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Fujifilm Holdings Corporation Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.
This research report has been segmented and sub-segmented into the following categories:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Ionizing Technologies
184.108.40.206 Digital Mammography
220.127.116.11 3D Mammography
18.104.22.168 Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
22.214.171.124 Positron Emission Tomography and Computed Tomography (PET-CT)
126.96.36.199 Cone-Beam Computed Tomography (CBCT)
188.8.131.52 Positron Emission Mammography (PEM)
5.1.3 Non-ionizing Technologies
184.108.40.206 Breast MRI
220.127.116.11 Breast Ultrasound
18.104.22.168 Automated Whole-Breast Ultrasound (AWBU)
22.214.171.124 Breast Thermography
126.96.36.199 Optical Imaging
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Type
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Type
6.1.5 Market Share Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Type
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Siemens Healthcare
8.4 Philips Healthcare
8.5 Fujifilm Holdings Corporation Gamma Medica Inc.
8.6 Toshiba Corporation
8.7 Sonocine Inc.
8.8 Aurora Imaging Technolog Inc.,
8.9 Dilon Technologies, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures